Seroprevalence of herpes simplex virus types 1 and 2 and correlates of infection in Jordan

Int J STD AIDS. 2022 Mar;33(3):304-310. doi: 10.1177/09564624211060183. Epub 2022 Jan 3.

Abstract

Background: Herpes infections are common infections among populations. Herein, a cross-sectional study was used to determine the seroprevalence of herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) IgG antibodies and their association with potential infection risk factors among Jordanians.

Methods: A total of 759 serum samples were collected (January to February 2020) and analyzed for HSV-1 and HSV-2 IgG antibodies by enzyme-linked immunosorbent assay. Estimates for population seropositivity were determined by weighting the age-specific seroprevalence by the size of the population in each age stratum.

Results: The population estimate for HSV-1 seroprevalence was 75.3%. After adjustment for possible confounders, regression analysis revealed higher seroprevalence with increase in age (p < 0.005) and low household income (p = 0.002). The population estimate for HSV-2 seroprevalence was 2.9%. No significant differences in HSV-2 seroprevalence were observed in association with age, gender, family size, educational level, and socioeconomic status, likely due to low seropositivity.

Conclusions: Jordanians have high HSV-1 and low HSV-2 seroprevalence. Periodical studies might be needed to evaluate changes in HSV-1 and HSV-2 seroprevalence over time. This study provides essential epidemiological data for Jordan and the Middle East and North Africa region.

Keywords: Herpes simplex virus; Middle East and North Africa; genital herpes; infection; oral herpes; risk factor; seroprevalence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • Cross-Sectional Studies
  • Herpes Genitalis* / epidemiology
  • Herpes Simplex* / epidemiology
  • Herpesvirus 1, Human*
  • Herpesvirus 2, Human
  • Humans
  • Jordan / epidemiology
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral